Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2026Biomedicine & PharmacotherapyOpen Access

Bridging the gap between experimental evidence and clinical applications of antipseudomonal phage therapy against Pseudomonas aeruginosa

View Full Paper
Ask AI
Bookmark
Share

Authors

AEAhmed ElfadadnyDamanhour UniversityWNWedad M. NageebSuez Canal UniversityRRRokaia F. RagabMinistry of Agriculture and Cooperatives

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Elfadadny et al. (2026) studied this question.

synapsesocial.com/papers/6ab60f92406bf401c14683f9https://doi.org/10.1016/j.biopha.2026.119894
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Overcoming the Phage Replication Threshold: a Mathematical Model with Implications for Phage Therapy2002 · 225 citations
  2. 2The History and Applications of Phage Therapy in Pseudomonas aeruginosa2021 · 17 citations
  3. 3Aztreonam Lysine Increases the Activity of Phages E79 and phiKZ against Pseudomonas aeruginosa PA012021 · 45 citations
  4. 4Early clinical experience of bacteriophage therapy in 3 lung transplant recipients2019 · 298 citations
  5. 5A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections2016 · 106 citations